Srinivas Sashidhar

Srinivas Sashidhar has a diverse work experience in the healthcare and life science industry, spanning over several roles and companies. Srinivas is currently a member of the Board of Advisors at UC Santa Barbara PaCE Customer Experience Certificate Program. Prior to this, they served as the Business Head - Clinical Research at myOnsite Healthcare, LLC. In 2019, they worked as a Domain Specialist - Life Sciences at Cloudbyz, and before that, they were an Independent Consultant for the healthcare and life science industry. Srinivas also worked as a Senior Industry Analyst at Infiniti Research Ltd. and as a Principal Research Analyst at ValGenesis, Inc. Srinivas gained valuable experience as an Industry Analyst at Frost & Sullivan India Pvt. Ltd., where they specialized in tracking and analyzing the life sciences industry. Srinivas began their career as an Associate Genetic Research Analyst at Histogenetics India Pvt Ltd and later worked as a Senior Research Scientist at Pondicherry Biotech Private Limited.

Srinivas Sashidhar holds a Master of Technology (M.Tech.) degree in Biotechnology from VIT University, which they obtained from 2006 to 2008. Prior to that, they obtained a Bachelor of Technology (B.Tech.) degree in Biotechnology from Sathyabama University, where they studied from 2002 to 2006. There is no available information regarding their education before university. In addition to their formal education, Srinivas has obtained various certifications, including Design-Led Strategy: Design thinking for business strategy and entrepreneurship by the University of Sydney, The Data Scientist's Toolbox by Johns Hopkins University, Salesforce Certified Administrator (SCA) by Salesforce, Design and Interpretation of Clinical Trials by Johns Hopkins University, Data Management for Clinical Research from Vanderbilt University, Salesforce Platform Basics from Trailhead by Salesforce, and Good Clinical Practice from The National Institutes of Health NIDA Clinical Trials Network. The dates of these certifications range from 2019 to 2023.